After a successful semester of Pycap Academy running its Venture Capital & Private Equity Course at the Schulich School of Business, Pycap CEO Stuart Browne and Operations Manager Amelia Dookhee participated in the convocation ceremony to congratulate their graduating students.

The Pycap Team was honoured to be a part of this experience and to have a positive impact on the students. Receiving endorsements such as "Your class ignited my passion in Venture Capital" and "I learned so much and loved the real world experience" as well as a course evaluation above the faculty mean helped validate the curriculum for Pycap and encouraged them to continue for the next semester.

Pycap got involved with Collision, one of the biggest tech conferences in the world. The City of Toronto invited Pycap to host a pub crawl for a large group of foreign tech attendees, leading them throughout numerous establishments in the downtown core.

Collision featured five main stages (and about a dozen smaller stages), 700 speakers, 1,100 startups and more than 25,000 attendees. Technologies featured at the event included artificial intelligence, machine learning, augmented reality, blockchain, virtual reality, augmented reality and many others.

Pycap, a venture capital firm based in Toronto, is excited to become an Investor Hub member at JLABS @ Toronto. As an Investor Hub Member,  Pycap joins 20+ other investor groups who come onsite to JLABS @ Toronto at different times each month or quarter for office hours. JLABS residents are able to book meetings with Pycap to receive guidance or be considered as a future investment for its Venture Capital Fund.

Johnson & Johnson Innovation - JLABS @ Toronto is a 40,000 square-foot life science innovation center. The labs provide a flexible environment for start-up companies pursuing new technologies and research platforms to advance medical care. Through a "no strings attached" model, Johnson & Johnson Innovation does not take an equity stake in the companies occupying JLABS and the companies are free to develop products - either on their own, or by initiating a separate external partnership with Johnson & Johnson Innovation or any other company.

One of Pycap’s mandates is to invest in early-stage technology companies with artificial intelligent solutions for the healthcare industry. Pycap sees JLABS as an ideal source for these investment opportunities.